Published in Vaccine Weekly, July 9th, 2003
Unlike traditional vaccines, DNA vaccines do not expose patients to pathogens, but rather express one or more genes from the disease agent, along with ancillary genes to program the immune response by the patient.
NTC scientists optimized the DNA vaccine delivery platform (vector) to outperform previous state-of-the-art vectors.
"Optimized vectors should overcome current technical limitations," said company spokesman Clague Hodgson, "including effectiveness, safety, and productivity."
The NTC vaccines contain...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly